Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
With a market cap of 150.42B, Pfizer(PFE) trades at $26.37. The stock has a price-to-earnings ratio of 15.21 and currently yields dividends of 6.6%.
On 2026-01-31, Pfizer(PFE) stock moved within a range of $25.90 to $26.47. With shares now at $26.37, the stock is trading +1.8% above its intraday low and -0.4% below the session's peak.
Trading volume for Pfizer(PFE) stock has reached 51.6M, versus its average volume of 51.54M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
PFE News
Pfizer (PFE) is back in focus after two fresh pipeline updates: a non-exclusive Matrix M vaccine adjuvant licensing deal with Novavax and FDA Breakthrough Thera...
If you are wondering whether Pfizer's current share price reflects its underlying value, you are not alone, many investors are asking the same question right no...
Key Points The coronavirus contagion created a brilliant but relatively short-lived opportunity. R&D work that had been put on hold earlier during the COVID-1...
Analyst ratings
57%
of 28 ratingsMore PFE News
The Trump administration has announced the names of 15 drugs targeted for Medicare price negotiations for 2028. The new list of branded medications announced by...
Pfizer (NYSE:PFE) has signed a licensing agreement with Novavax for non-exclusive global rights to use Matrix-M adjuvant technology in vaccines for up to two in...
Pfizer Inc. (NYSE:PFE) shares are trading higher on Tuesday, as the stock benefits from a price forecast increase at Cantor Fitzgerald. The firm raised its for...
Cantor Fitzgerald raised the firm’s price target on Pfizer (PFE) to $27 from $24 and keeps a Neutral rating on the shares. With 2026 guidance already issued and...
Pfizer Inc (PFE), Biontech Se Sponsored Adr (BNTX) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Pfizer-BioNTech Advance...
Key Points Pfizer's deep pipeline could prove its greatest asset, helping it bounce back. Viking Therapeutics is developing a highly promising weight loss med...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.